Physician profile
Vikram Oke
NPI 1285905158
$7,336.55
in general payments reported to CMS, 2019-2025
10 companies · $1,748 in 2025
The $1,748 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2022: $138 · 2023: $428 · 2024: $4,865 · 2025: $1,748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Food and Beverage: $922 · Travel and Lodging: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Food and Beverage | $922.42 |
| Travel and Lodging | $619.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,167.76 | 2024-2025 | |
| Glaxosmithkline, LLC. | $987.80 | 2019-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Philips North America LLC | $39.65 | 2024-2025 | Vest Therapy Und, (8874) Incourage |
| Grifols USA, LLC | $26.98 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.84 | 2023 | Jardiance |
| Harmony Biosciences LLC | $22.65 | 2025 | |
| Galvanize Therapeutics, INC | $21.38 | 2025 | Aliya System |
| Genzyme Corporation | $20.52 | 2025 | |
| Ambu INC. | $13.94 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $13.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Oke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.